A mini-invasive surgical technique for Carlevale IOL implantation: case series study and description of concomitant surgery.

"Declarations Informed consentInformed consent was obtained from all the patients before every single surgical operation. They also provided informed consent for publication of the images. Ethics approvalThis is a retrospective study, so no approval from Ethics Committee was required. The study was performed according to the 1964 Declaration of Helsinki and its later amendments. Conflict of interestCarla Danese is consultant for Bayer, outside the submitted work. Francesco Di Bin declares no conflicts of interest. Paolo Lanzetta is consultant for Aerie, Allergan, Apellis, Bausch&Lomb, Bayer, Biogen, Boerhinger, Centervue, Genentech, Novartis, Ocular Therapeutix, Outlook Therapeutics, Roche, outside the submitted work. Conflict of interest Carla Danese is consultant for Bayer, outside the submitted work. Francesco Di Bin declares no conflicts of interest. Paolo Lanzetta is consultant for Aerie, Allergan, Apellis, Bausch&Lomb, Bayer, Biogen, Boerhinger, Centervue, Genentech, Novartis, Ocular Therapeutix, Outlook Therapeutics, Roche, outside the submitted work."

"Funding Open access funding provided by Università degli Studi di Udine within the CRUI-CARE Agreement."